Baker A H, Wilkinson G W, Hembry R M, Murphy G, Newby A C
Department of Cardiology, University of Wales College of Medicine, Cardiff, UK.
Matrix Biol. 1996 Dec;15(6):383-95. doi: 10.1016/s0945-053x(96)90158-4.
Remodelling of the extracellular matrix resulting from increased secretion of metalloproteinase enzymes (MMPs) is implicated in many pathological conditions, including rheumatoid arthritis, restenosis following balloon angioplasty, atherosclerosis and cancer cell invasion and metastasis. Clear definition of the normal and pathological function of individual MMPs will benefit from approaches that use gene transfer to produce increases in MMP levels that mimic those observed in pathological conditions. Similarly, gene transfer methods leading to controlled increases in levels of the tissue inhibitor of metalloproteinases (TIMPs) will help to define the function of MMPs both in vitro and in vivo. Gene transfer of TIMPs may also have therapeutic potential in pathological conditions where inhibition of MMP activity may be beneficial. We have used the adenovirus serotype 5 vector system to generate replication-deficient recombinant adenoviruses capable of expressing the MMP-9, TIMP-1 or -2 genes. High level expression is driven by the cytomegalovirus major immediate early promoter (CMV IEP). Efficient and selective over-production of each recombinant protein was shown by immunofluorescence in either rabbit smooth muscle cells (SMC) or human MCF-7 adenocarcinoma cells. High level secretion directly dependent on the multiplicity of infection (MOI) was observed for each functional transgene by gelatin zymography. Using a quantitative ELISA assay, levels of recombinant TIMP-1 were detected when SMC were infected with as low as three plaque forming units (pfu) of virus per cell in vitro. A linear increase in TIMP-1 secretion was observed up to 1000 pfu/cell of virus (0.75 ng/10(4) cells/24 h at 3 pfu/cell to 1243 ng/10(4) cells/24h at 1000 pfu/cell). Similar levels of secretion of MMP-9 and TIMP-2 were observed by Western blot analysis using the same MOI of adenovirus. Thus, recombinant adenoviruses are an efficient and flexible system for high level expression of MMPs and TIMPs and will be useful tools in the study of matrix remodelling in vivo and in vitro.
金属蛋白酶(MMPs)分泌增加导致的细胞外基质重塑与许多病理状况有关,包括类风湿性关节炎、球囊血管成形术后再狭窄、动脉粥样硬化以及癌细胞侵袭和转移。采用基因转移方法使MMP水平升高以模拟病理状况下所观察到的水平,这将有助于明确各个MMP的正常和病理功能。同样,能使金属蛋白酶组织抑制剂(TIMPs)水平得到可控升高的基因转移方法,将有助于在体外和体内明确MMP的功能。在MMP活性抑制可能有益的病理状况下,TIMP的基因转移也可能具有治疗潜力。我们已利用5型腺病毒载体系统来生成能够表达MMP-9、TIMP-1或-2基因的复制缺陷型重组腺病毒。高水平表达由巨细胞病毒主要立即早期启动子(CMV IEP)驱动。通过免疫荧光在兔平滑肌细胞(SMC)或人MCF-7腺癌细胞中均显示出每种重组蛋白的高效且选择性过量产生。通过明胶酶谱法观察到,每个功能性转基因的高水平分泌直接依赖于感染复数(MOI)。使用定量ELISA测定法,当体外每细胞用低至三个噬斑形成单位(pfu)的病毒感染SMC时,可检测到重组TIMP-1的水平。观察到TIMP-1分泌呈线性增加,直至病毒为1000 pfu/细胞(每细胞3 pfu时为0.75 ng/10⁴细胞/24小时,至每细胞1000 pfu时为1243 ng/10⁴细胞/24小时)。使用相同MOI的腺病毒通过蛋白质免疫印迹分析观察到MMP-9和TIMP-2的分泌水平相似。因此,重组腺病毒是用于MMP和TIMP高水平表达的高效且灵活的系统,将成为体内外基质重塑研究中的有用工具。